Ligandal, Inc.
PrivateLast Round
Series A
May 1, 2019
Total Funding Raised
$17M
Company Overview
Ligandal, Inc. operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series A round in May 2019.
Ligandal, Inc. is a biotechnology company that develops peptide-based delivery technologies for gene therapy, gene editing, and regenerative medicine.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ligandal, Inc. Comparables
Compare Ligandal, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| STRM.BIO | 85% | |
| Code Biotherapeutics | 84% | |
| NTrans Technologies | 84% |
For institutional investors. Book with your work email.
Ligandal, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ligandal, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gaingels | Seed |
| Bioverge | Seed |
| Flucas Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 1, 2019
$15M round completed.
For institutional investors. Book with your work email.
Ligandal, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ligandal, Inc.'s valuation, stock price, and market status.
Is Ligandal, Inc. a public or private company?
Ligandal, Inc. is a private company.
What is the current stock price of Ligandal, Inc.?
Ligandal, Inc. is a private company, so its shares have no public market price. Caplight tracks Ligandal, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ligandal, Inc. worth (valuation)?
Valuation information for Ligandal, Inc. is not publicly available.
Can I buy Ligandal, Inc. stock?
Ligandal, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ligandal, Inc.'s last funding round?
Ligandal, Inc.'s most recent funding round was Series A on May 1, 2019.
Who are the main investors in Ligandal, Inc.?
Key investors in Ligandal, Inc. include Gaingels, Bioverge, Flucas Ventures.
Will Ligandal, Inc. IPO soon?
No public IPO plans have been announced for Ligandal, Inc..
How can I track Ligandal, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Ligandal, Inc.'s shares on secondary markets.